CLINICAL_TRIALS
trial_result
· 2016-05-18
Clinical Trial Update: A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation [Phase 1]
Summary
This Phase 1 study compared the bioavailability of LGD-6972 when administered as a capsule versus an oral solution.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ligand Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED